Bliss GVS Pharma
BLISSGVS · Pharma > Pharmaceuticals & Drugs · Chairman: S R Vaidya · MD: Gagan Harsh Sharma · Listing date: July 26, 2010 · Employees: 683 · Mumbai · http://www.blissgvs.com

Stock Price vs Company Growth
1d
6.8%
1w
9.4%
1m
3.4%
3m
2.1%
6m
20.9%
1y
4.7%
5y
0.9%
10y
7.6%
all
9.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 129 6.8%
107
143
Company Overview

Sales
800 Cr
Growth: 7.1%
Profit after Tax
63.4 Cr
Growth: -22.2%
Small Cap
1,359 Cr
P/E: 21.6x
Industry P/E: 35.6x
Fundamentals

Sales (Cr) ₹ 800
Growth 7.1%
EBITDA 18.5%
P/S 1.7x
Dividend 0.6%
P/E 21.6x
Book Value ₹ 1
PEG Ratio 3.1x
ROE 604.9%
P/B N/A
Shareholding Pattern

Institutions
Arian Investment Ltd
9.7 %
Life Insurance Corporation Of India
6.68 %
Polus Global Fund
4.62 %
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund
2.9 %
Aspire Emerging Fund
2.46 %
Promoters
Narsimha Shibroor Kamath
33.24 %
Others
Gulbarga Trading And Investment Pvt. Ltd.
5.67 %
Arjun Gautam Ashra
4.89 %
Gautam Rasiklal Ashra
2.82 %
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs
2.2 %
Llp
0.05 %
Increase    Decrease    No change
Company Profile Detailed

It is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. The company’s most unique product is ‘Today Vaginal Contraceptive’, a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception.
Investors (60)
Followers (10)